Patents by Inventor Jacques Bodennec

Jacques Bodennec has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8168167
    Abstract: The invention relates to a method for biologically combating the proliferation of Legionella pneumophila, with the exception of the treatment methods applied to the human or animal body, characterized in that it uses amoebic protozoa of the species Willaerita magna, corresponding to the strain deposited with the ATCC under number PTA-7824 or the strain deposited with the ATCC under number PTA-7825.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: May 1, 2012
    Assignee: Universite Claude Bernard Lyon I
    Inventors: Jacques Bodennec, Rafik Dey, Pierre Pernin
  • Publication number: 20100119485
    Abstract: The invention relates to a method for biologically combating the proliferation of Legionella pneumophila, with the exception of the treatment methods applied to the human or animal body, characterized in that it uses amoebic protozoa of the species Willaerita magna, corresponding to the strain deposited with the ATCC under number PTA-7824 or the strain deposited with the ATCC under number PTA-7825.
    Type: Application
    Filed: October 12, 2007
    Publication date: May 13, 2010
    Inventors: Jacques Bodennec, Rafik Dey, Pierre Pernin
  • Patent number: 7429460
    Abstract: The present invention discloses methods of screening for identification of compounds that inhibit novel targets in the enzymatic pathway of phospholipid synthesis that are related to glycolipid storage diseases, and use of the compounds for treating patients affected with glycolipid storage diseases, particularly Gaucher disease. Specifically, the compounds of the present invention are intended to inhibit the accumulation of phosphatidylcholine (PC), wherein PC accumulation is increased due to the activation of CTP:phosphocholine cytidylyltransferase (CCT) upon glucosylceramide (GlcCer) accumulation.
    Type: Grant
    Filed: January 15, 2003
    Date of Patent: September 30, 2008
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Anthony H. Futerman, Jacques Bodennec, Dori Pelled
  • Publication number: 20040137531
    Abstract: The present invention discloses methods of screening for identification of compounds that inhibit novel targets in the enzymatic pathway of phospholipid synthesis that are related to glycolipid storage diseases, and use of the compounds for treating patients affected with glycolipid storage diseases, particularly Gaucher disease. Specifically, the compounds of the present invention are intended to inhibit the accumulation of phosphatidylcholine (PC), wherein PC accumulation is increased due to the activation of CTP:phosphocholine cytidylyltransferase (CCT) upon glucosylceramide (GlcCer) accumulation.
    Type: Application
    Filed: January 15, 2003
    Publication date: July 15, 2004
    Inventors: Anthony H. Futerman, Jacques Bodennec, Dori Pelled, Christian Riebeling, Selena Trajkovic